Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 29, 2016Circulation ResearchOpen Access

Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAnthony KanelidisUniversity of ChicagoCPCourtney PremerNorthwestern UniversityJLJuan José Navarro LópezUniversidad de Ciencias Médicas de Cienfuegos

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kanelidis et al. (2016) studied this question.

synapsesocial.com/papers/6a70de0835aa2c282ce232b5https://doi.org/10.1161/circresaha.116.309819
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incomplete retention after direct myocardial injection2002 · 137 citations
  2. 2Mesenchymal Stem Cell Delivery Routes and Fate2008 · 236 citations
  3. 3Cardiac Stem Cell Treatment in Myocardial Infarction2016 · 159 citations
  4. 4Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting2014 · 355 citations
  5. 5Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease2015 · 170 citations